| CANCER FOUNDATION OF SANTA BARBARA | 952158727 | 2017-12-31 | $8.5M | DIAGNOSING, TREATING, RESEARCHING, & GENERAL CANCER CARE |
| CANCER FOUNDATION OF SANTA BARBARA | 952158727 | 2018-12-31 | $3.6M | DIAGNOSING, TREATING, RESEARCHING, & GENERAL CANCER CARE |
| CANCER FOUNDATION OF SANTA BARBARA | 952158727 | 2024-12-31 | $3.5M | GENERAL CANCER CARE |
| CANCER FOUNDATION OF SANTA BARBARA | 952158727 | 2019-12-31 | $3.3M | DIAGNOSING, TREATING, RESEARCHING, & GENERAL CANCER CARE |
| CANCER FOUNDATION OF SANTA BARBARA | 952158727 | 2022-12-31 | $3.1M | DIAGNOSING, TREATING, RESEARCHING, & GENERAL CANCER CARE |
| CANCER FOUNDATION OF SANTA BARBARA | 952158727 | 2016-12-31 | $2.5M | DIAGNOSING, TREATING, RESEARCHING, & GENERAL CANCER CARE |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | 110303001 | 2022-06-30 | $1.0M | For grant recipient's exempt purposes |
| JEWISH COMMUNAL FUND | 237174183 | 2023-06-30 | $1.0M | IN FURTHERANCE OF GRANTEE'S TAX-EXEMPT PURPOSE |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | 110303001 | 2019-06-30 | $683K | For grant recipient's exempt purposes |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | 110303001 | 2018-06-30 | $513K | FOR GRANT RECIPIENT'S EXEMPT PURPOSES |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | 110303001 | 2017-06-30 | $508K | For grant recipient's exempt purposes |
| CALIFORNIA COMMUNITY FOUNDATION | 953510055 | 2023-06-30 | $500K | HEALTH |
| JEWISH COMMUNAL FUND | 237174183 | 2016-06-30 | $250K | Unrestricted General Support |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | 110303001 | 2023-06-30 | $105K | For grant recipient's exempt purposes |
| PETOSKEY-HARBOR SPRINGS AREA COMMUNITY FOUNDATION | 383032185 | 2024-03-31 | $101K | IN THE NAMES OF, AND IN MEMORY OF, MICHAEL THAIN CAMERON AND MARTHA CAVANAGH CAMERON, TO BE USED AT THE DIRECTION OF KURT N. RANSOHOFF, M. D., CEO AND PRESIDENT OF THE CLINIC, TO FURTHER THE CLINIC'S MEDICAL SERVICES OR RESEARCH |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | 110303001 | 2024-06-30 | $84K | For grant recipient's exempt purposes |